Kerendia is indicated to reduce the risk of sustained eGFR decline,end-stage kidney disease,cardio
Kerendia is used to treat Chronic Kidney Disease (CKD) in adult patients with Type II Diabetes. The active composition of Kerendia is Finerenone. It reduces the risk of worsening of Kidney disease, Kidney failure and death due to cardiovascular disease. Dose is once daily.
Production Capacity: 200
Delivery Time: 4 to 6 days
Packaging Details: 10 tablets + 4 tablets free per strip